Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09FMS
|
|||
| Drug Name |
PMID27376512-Compound-Table1Example5
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
IKERCHEM S L [ESUNIV DEL PA S VASCO [ES]
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C23H19NO8
|
|||
| Canonical SMILES |
COC1=CC2=C(C=C1)C(=CN2CC(=O)C3=C(C(=C(C=C3)O)O)O)C4=C(C(=C(C=C4)O)O)O
|
|||
| InChI |
1S/C23H19NO8/c1-32-11-2-3-12-15(13-4-6-17(25)22(30)20(13)28)9-24(16(12)8-11)10-19(27)14-5-7-18(26)23(31)21(14)29/h2-9,25-26,28-31H,10H2,1H3
|
|||
| InChIKey |
SFHIQZITSGPFGB-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | DNA [cytosine-5]-methyltransferase 1 (DNMT1) | Target Info | Inhibitor | [1] |
| Target's Patent Info | DNA [cytosine-5]-methyltransferase 1 (DNMT1) | Target's Patent Info | [1] | |
| KEGG Pathway | Cysteine and methionine metabolism | |||
| Metabolic pathways | ||||
| MicroRNAs in cancer | ||||
| Pathwhiz Pathway | Methionine Metabolism | |||
| Pathway Interaction Database | Regulation of retinoblastoma protein | |||
| Reactome | PRC2 methylates histones and DNA | |||
| NoRC negatively regulates rRNA expression | ||||
| DNA methylation | ||||
| WikiPathways | Trans-sulfuration and one carbon metabolism | |||
| Retinoblastoma (RB) in Cancer | ||||
| One Carbon Metabolism | ||||
| Trans-sulfuration pathway | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | DNA methyltransferase inhibitors: an updated patent review (2012-2015).Expert Opin Ther Pat. 2016 Sep;26(9):1017-30. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.